Effect of Ruboxistaurin on Blood–Retinal Barrier Permeability in Relation to Severity of Leakage in Diabetic Macular Edema

Authors:

Abstract
Purpose. The purpose of the study was to investigate the effect of orally administered ruboxistaurin (RBX, LY333531), a selective protein kinase C β inhibitor, on the permeability of the blood–retinal barrier in patients with diabetic macular edema.